Your browser doesn't support javascript.
Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020.
Maurer, Florian P; Shubladze, Natalia; Kalmambetova, Gulmira; Felker, Irina; Kuchukhidze, Giorgi; Drobniewski, Francis; Yedilbayev, Askar; Ehsani, Soudeh.
  • Maurer FP; National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Shubladze N; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kalmambetova G; National Reference Laboratory, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Felker I; National TB Reference Laboratory, Bishkek, Kyrgyzstan.
  • Kuchukhidze G; Scientific department, Novosibirsk Tuberculosis Research Institute, Novosibirsk, Russia.
  • Drobniewski F; Regional Office for Europe, World Health Organization, Copenhagen, Denmark.
  • Yedilbayev A; Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Ehsani S; Regional Office for Europe, World Health Organization, Copenhagen, Denmark.
Euro Surveill ; 26(24)2021 06.
Article in English | MEDLINE | ID: covidwho-1278341
ABSTRACT
We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.ES.2021.26.24.2100426

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.ES.2021.26.24.2100426